eConsent Solutions
-
Just The Facts: Direct Data Capture
5/20/2022
Start enabling direct data capture (DDC), clinical outcome assessments (eCOA), patient reported outcomes (ePRO), and eConsent with the Clinical ink platform.
-
Technology Solutions And Services Tailored For Emerging Biopharma
1/16/2024
Explore how this collection of solutions and services is transforming clinical trials and empowering emerging biopharma organizations to revolutionize medicine.
-
A Clinical Research Toolset That Delivers Power And Ease Of Use
1/23/2024
Improve experiences and outcomes in clinical trials with a robust, and modern toolset of best-in-class solutions for eSource, ePRO, data capture, reporting, and more.
-
CRIO eConsent: Never Miss Another Re-Consent
9/7/2022
CRIO eConsent is unique. It checks whether patients have executed the most recent informed consent at the outset of each visit.
-
Introducing One Home for Sites™
2/8/2024
Join the movement to increase clinical research site capacity. IQVIA One Home for Sites serves as a neutral aggregator, connector, and communicator of the key systems and tasks sites need to perform.
-
EDC: Control Your Data, Control Your Study
2/16/2023
Streamline data, maximize efficiencies, tighten up costs, and reach end goals faster using Medrio’s powerful and intuitive EDC tool.
-
Medrio eConsent
10/5/2023
Flexible consent technology improves participant comprehension and process oversight. Learn how Medrio’s eConsent solution is empowering organizations to accelerate all aspects of the consent process.
-
Optimizing RSV Vaccine Trials For A Healthier Tomorrow
2/20/2024
Vaccine trials pose unique challenges; that's why sponsors and CROs trust us to navigate complexities and capture audit-ready, high-quality evidence required to get new vaccines to patients.
-
Advance Your Study With Medrio's Electronic Data Capture (EDC)
6/19/2023
How you capture study data can make or break your organizational success, so why settle? Medrio’s EDC technology is intuitive, scalable, and proven across over 8,000 studies.